Trial intelligence / Profile preview

EXPLOR: Amlodipine/Valsartan vs Atenolol/Amlodipine in Hypertension

NCT00687973Phase 4Completed

Sponsor
Novartis
Start
Jan 2008
Primary completion
Jan 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of valsartan in essential hypertension, sponsored by Novartis. Started Jan 2008; status: completed.

02

Drugs

valsartan
03

Conditions

essential hypertension

Beyond the preview

Go deeper on NCT00687973.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00687973.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call